Anti-human CTLA4 monoclonal antibody, ipilimumab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1057-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: BMS-734016, MDX-010, MDX-CTLA-4
target CTLA4
alias CTLA4, CD152
gene id Uniprot ID: P16410
host species Human
reactivity Human
iso type Human IgG1 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications ELISA, Flow Cyt
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

ELISA plate pre-coated by 2 ug/ml (100 ul/well) Human CTLA4, hFc tagged protein binds to Anti-CTLA4 Neutralizing antibody in a linear range of 0.64-80.0 ng/ml.

HEK293 cell line transfected with irrelevant protein (B) and human CTLA4 (A) were surface stained with anti-CTLA4 neutralizing antibody 1ug/ml (ipilimumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.

ELISA plate pre-coated by 2 ug/ml (100 ul/well) Human CTLA4, mFc-His tagged protein binds to Anti-CTLA4 Neutralizing antibody in a linear range of 0.13-16.0 ng/ml.


PRODUCT

  • SKU

    DMS1057-100ug

  • Size

    100ug

  • Price

    $350

1